The Vanguard Group 13D/13G Filings for Ovid Therapeutics Inc. (OVID)

The Vanguard Group 13D and 13G filings for Ovid Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-09
11:30 am
Sale		 2022-12-30 13G Ovid Therapeutics Inc.
OVID		 The Vanguard Group 2,581,736
3.660%		 -860,882decrease
(-25.01%)		 Filing
2022-02-10
08:32 am
Purchase		 2021-12-31 13G Ovid Therapeutics Inc.
OVID		 The Vanguard Group 3,442,618
5.060%		 3,442,618increase
(New Position)		 Filing